Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Disease Area Omics, Analytical science, Cancer

Monitoring Kinome Adaptations to Therapy using Quantitative High Resolution Mass Spectrometry

sponsored by Thermo Fisher Scientific

June 23, 2016 8:00 AM PDT 11:00 AM EST

Register Free

Historically, researchers have utilized technologies such as qRT-PCR, Taqman Gene expression assays, western blotting, and liquid chromatography mass spectrometry that allow them to look at single kinases in a relatively linear fashion. Learn how studying the kinome as a whole entity, using additional technologies like quantitative high resolution orbital mass spectrometry, can aide in understanding how tumors may evade current therapies by altering their kinome state. Using this information, learn how clinical translational researchers are investigating new and potentially more effective kinase inhibitor combination therapies for complex diseases like cancer.

Key Learning Objectives:

What you will learn:

  • Define methods to study protein kinome “en masse” using chemical proteomics.
  • Identify novel kinase inhibitor combinations that overcome drug resistance.
  • Explore the function of protein kinases that represent the (un) targeted kinome.
Hosted by
Charlotte Barker, Editor, The Translational Scientist
James S. Duncan, PhD Assistant Professor, Fox Chase Cancer Center at Temple Health
Sponsored by

Register Free

Enjoy our FREE content!

Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!

Login if you already created an account

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Or Login as a Guest or via Social Media

Related Solutions

Disease Area

See how droplets are guiding precision medicine

| Contributed by Bio Rad

Disease Area

Improving Absorption Measurements through Light Source Selection

| Contributed by Ocean Optics


Send me the latest from The Translational Scientist.

Sign up now

Related Articles

Disease Area

More than METs the Eye

| Jonathan James

Tools & Techniques

The Epigenomic Explorer

Research Field

Celebrating the Digital Age

| Sophie Kornowski-Bonnet

Most Popular

Register here

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts